Clinical Trial Update: Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating daily ospemifene for vulvar and vaginal changes related to vulovaginal atrophy and dyspareunia; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia
• Vulvar Disorders
• Vulvovaginal Atrophy

Drugs mentioned

• Ospemifene (ospemifene)

Snippet

Sponsor: Sue Goldstein | Conditions: Vulvovaginal Atrophy, Dyspareunia | Phase 4 | Status: COMPLETED | Results posted: 2019-04-02